112 related articles for article (PubMed ID: 16294944)
1. Etanercept injection site reaction.
Clelland S; Hunek JR
Dermatol Nurs; 2005 Oct; 17(5):375-. PubMed ID: 16294944
[No Abstract] [Full Text] [Related]
2. Acute injection site reaction to intraarticular etanercept administration.
Arnold EL; Khanna D; Paulus H; Goodman MP
Arthritis Rheum; 2003 Jul; 48(7):2078-9. PubMed ID: 12847708
[No Abstract] [Full Text] [Related]
3. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
4. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.
Stinco G; Piccirillo F; Patrone P
Acta Derm Venereol; 2008; 88(3):281-2. PubMed ID: 18480934
[No Abstract] [Full Text] [Related]
5. Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.
Menè P; Franeta AJ; Conti G; Stoppacciaro A; Chimenz R; Fede A; Gallizzi R; Fede C
Clin Exp Rheumatol; 2010; 28(1):91-3. PubMed ID: 20346246
[TBL] [Abstract][Full Text] [Related]
6. Worsening injection site reactions with continued use of etanercept.
Edwards KR; Mowad CM; Tyler WB
J Drugs Dermatol; 2003 Apr; 2(2):184-7. PubMed ID: 12852371
[TBL] [Abstract][Full Text] [Related]
7. Etanercept for psoriatic arthritis.
Gladman DD
BMJ; 2010 Feb; 340():c229. PubMed ID: 20124564
[No Abstract] [Full Text] [Related]
8. [Etanercept].
Mühlhäuser U; Münzel F; Eschenhagen T
Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
[No Abstract] [Full Text] [Related]
9. [Active WHO class IV lupus nephritis in a patient treated with etanercept for a psoriasic arthritis].
Sacquépée M; Rouleau V; Cantin JF; Quirin N; Doussy Y; Valéry JC; Picu C; Tivollier JM
Nephrol Ther; 2010 Nov; 6(6):537-40. PubMed ID: 20599469
[TBL] [Abstract][Full Text] [Related]
10. Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case?
Patruno C; Balato N; Cirillo T; Napolitano M; Ayala F
Dermatol Ther; 2013; 26(6):493-5. PubMed ID: 24552415
[TBL] [Abstract][Full Text] [Related]
11. Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen.
Borrás-Blasco J; Gracia-Pérez A; Casterá MD; Rosique-Robles JD; Abad J
Expert Opin Biol Ther; 2013 Aug; 13(8):1103-8. PubMed ID: 23675687
[TBL] [Abstract][Full Text] [Related]
12. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
Delaunay C; Farrenq V; Marini-Portugal A; Cohen JD; Chevalier X; Claudepierre P
J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699
[TBL] [Abstract][Full Text] [Related]
13. Neutropenia after the third cycle of etanercept: could it be due to immunogenicity?
Olsen NJ; Elmagboul N
J Clin Rheumatol; 2014 Jun; 20(4):237-8. PubMed ID: 24847756
[No Abstract] [Full Text] [Related]
14. Recall injection-site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis.
González-López MA; Martínez-Taboada VM; González-Vela MC; Blanco R; Fernández-Llaca H; Rodríguez-Valverde V; Val-Bernal JF
Clin Exp Dermatol; 2007 Nov; 32(6):672-4. PubMed ID: 17953638
[TBL] [Abstract][Full Text] [Related]
15. Etanercept (Enbrel) -- an update.
Goffe B
Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
[TBL] [Abstract][Full Text] [Related]
16. Development of pseudogout during etanercept treatment.
Josefina M; Ana CJ; Ariel V; Silvio AA
J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
[No Abstract] [Full Text] [Related]
17. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection.
Winfield H; Lain E; Horn T; Hoskyn J
Arch Dermatol; 2006 Feb; 142(2):218-20. PubMed ID: 16490850
[TBL] [Abstract][Full Text] [Related]
18. Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept.
Gaudio A; Corrado A; Santoro N; Maruotti N; Cantatore FP
Int J Immunopathol Pharmacol; 2013; 26(1):229-33. PubMed ID: 23527726
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
[TBL] [Abstract][Full Text] [Related]
20. Results from an open-label extension study of etanercept in ankylosing spondylitis.
Davis J; Webb A; Lund S; Sack K
Arthritis Rheum; 2004 Apr; 51(2):302-4. PubMed ID: 15077279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
